SCHEDULE 13G

Company

Sunshine Biopharma Inc.

Filed

July 29, 2021

Accession Number

0001099910-21-000084

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →